Point72 Hong Kong LTD Krystal Biotech, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$39.81 - $88.24 $90,607 - $200,834	-2,276 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$52.01 - $71.77 $116,086 - $160,190	2,232 Added 5072.73%	2,276 $119,000
Q2 2021 Aug 16, 2021	BUY	$62.14 - $81.82 $2,734 - $3,600	44 New	44 $3,000
Q3 2020 Nov 16, 2020	SELL	$37.76 - $48.49 $6,494 - $8,340	-172 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $6,369 - $10,320	172 New	172 $7,000

310

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.89B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.